<PAGE>
DRESDNER RCM GLOBAL FUNDS
SUPPLEMENT DATED AUGUST 18, 2000
TO THE PROSPECTUS DATED MAY 1, 2000
THE FOLLOWING INFORMATION REPLACES SIMILAR INFORMATION FOUND UNDER THE
SUBHEADING "GLOBAL HEALTH CARE FUND AND BIOTECHNOLOGY FUND" AT PAGES 32 AND 33
OF THE PROSPECTUS.
Faraz Naqvi, M.D. and Michael Dauchot, M.D. are primarily responsible for the
day to day management of the Global Health Care Fund. Dr. Naqvi and Camilo
Martinez, M.D., Ph.D., are primarily responsible for the day to day management
of the Biotechnology Fund. Dr. Martinez is a research analyst of the Investment
Manager, with which he has been associated since 1999. Prior to joining the
Investment Manager, he practiced Internal Medicine at Northeast Valley Health in
1999 and at Century Group Medicine in 1998, both in southern California. From
1995-1998 Dr. Martinez was a resident at the University of California at Los
Angeles Department of Medicine. He is also a Board Certified physician in
Internal Medicine.
